Randomized, double-blinded, phase II trial of a WT1 peptide vaccine as adjuvant therapy in patients with malignant pleural mesothelioma (MPM) Meeting Abstract


Authors: Krug, L. M.; Tsao, A. S.; Kass, S.; Rusch, V. W.; Travis, W. D.; Panageas, K.; Adusumili, P. S.; Kris, M. G.; Maslak, P. G.; Scheinberg, D. A.
Abstract Title: Randomized, double-blinded, phase II trial of a WT1 peptide vaccine as adjuvant therapy in patients with malignant pleural mesothelioma (MPM)
Meeting Title: 47th Annual Meeting of the American Society of Clinical Oncology (ASCO)
Journal Title: Journal of Clinical Oncology
Volume: 29
Issue: 15 Suppl.
Meeting Dates: 2011 Jun 3-7
Meeting Location: Chicago, IL
ISSN: 0732-183X
Publisher: American Society of Clinical Oncology  
Date Published: 2011-05-20
Language: English
ACCESSION: WOS:000208880304564
DOI: 10.1200/jco.2011.29.15_suppl.tps139
PROVIDER: wos
Notes: Meeting Abstract: TPS139 -- Source: Wos
Altmetric Score
MSK Authors
  1. Valerie W Rusch
    657 Rusch
  2. Lee M Krug
    211 Krug
  3. William D Travis
    552 Travis
  4. Katherine S Panageas
    331 Panageas
  5. Peter Maslak
    168 Maslak
  6. Mark Kris
    612 Kris
  7. Samantha Lindsay Kass
    9 Kass